The United Nations Intergovernmental Panel on Climate Change (IPCC) issued its latest assessment on global efforts to address climate change and the dire consequences if we don't heed the warnings.
Some view the COVID-19 pandemic as a reputational turning point for pharma and an opportunity to solidify a more positive impact on society. Many pharmaceutical companies are furthering this goal by incorporating ESG into their operations.
